• Je něco špatně v tomto záznamu ?

Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures

D. Hoskovec, Z. Krška, M. Vočka, S. Argalácsová, P. Dytrych

. 2024 ; 16 (8) : . [pub] 20240419

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24012969

Grantová podpora
without number Cooperatio Program, research area Surgical Disciplines, Abdominal Surgery
without number Ministry of Health, Czech Republic-conceptual development of research organization 00064165, General University Hospital in Prague

PIPAC is a new and promising technique for the intraperitoneal administration of chemotherapy. It can be used in patients with various peritoneal cancer metastases. It is mainly a palliative treatment, but there is some neoadjuvant treatment potential. We have operated on 41 patients with various intra-abdominal cancers. PIPAC was performed every 6 weeks. The indication was extension of peritoneal carcinomatosis beyond the criteria for cytoreductive surgery and HIPEC. The effect was evaluated according to the peritoneal cancer index, the peritoneal regression grading score and the amount of ascites. Complications were classified according to the Clavien-Dindo system. We have performed 100 PIPAC procedures. There were two major complications, classified as Clavien Dindo III (2%). The number of procedures varied from 1 to 6. Five patients switched to cytoreductive surgery and HIPEC, and one was indicated for the watch and wait strategy due to total regression according to PRGS. Three patients are still continuing treatment. The others stopped treatment mainly because of progression of the disease and loss of metastases. We observed a reduction in ascites production soon after PIPAC application. PIPAC is a safe and well-tolerated treatment modality. It is mainly a palliative treatment that can improve the quality of life by reducing the production of ascites, but in about 10% of cases, it can reduce the extent of the disease and allow for further radical treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24012969
003      
CZ-PrNML
005      
20240726151454.0
007      
ta
008      
240723s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/cancers16081559 $2 doi
035    __
$a (PubMed)38672641
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hoskovec, David $u 1st Department of Surgery, General University Hospital, 128 08 Prague, Czech Republic $u 1st Medical Faculty, Charles University, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000329488989 $7 xx0076636
245    10
$a Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures / $c D. Hoskovec, Z. Krška, M. Vočka, S. Argalácsová, P. Dytrych
520    9_
$a PIPAC is a new and promising technique for the intraperitoneal administration of chemotherapy. It can be used in patients with various peritoneal cancer metastases. It is mainly a palliative treatment, but there is some neoadjuvant treatment potential. We have operated on 41 patients with various intra-abdominal cancers. PIPAC was performed every 6 weeks. The indication was extension of peritoneal carcinomatosis beyond the criteria for cytoreductive surgery and HIPEC. The effect was evaluated according to the peritoneal cancer index, the peritoneal regression grading score and the amount of ascites. Complications were classified according to the Clavien-Dindo system. We have performed 100 PIPAC procedures. There were two major complications, classified as Clavien Dindo III (2%). The number of procedures varied from 1 to 6. Five patients switched to cytoreductive surgery and HIPEC, and one was indicated for the watch and wait strategy due to total regression according to PRGS. Three patients are still continuing treatment. The others stopped treatment mainly because of progression of the disease and loss of metastases. We observed a reduction in ascites production soon after PIPAC application. PIPAC is a safe and well-tolerated treatment modality. It is mainly a palliative treatment that can improve the quality of life by reducing the production of ascites, but in about 10% of cases, it can reduce the extent of the disease and allow for further radical treatment.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Krška, Zdeněk $u 1st Department of Surgery, General University Hospital, 128 08 Prague, Czech Republic $u 1st Medical Faculty, Charles University, 120 00 Prague, Czech Republic $1 https://orcid.org/0000000217667472 $7 jn19990209431
700    1_
$a Vočka, Michal $u 1st Medical Faculty, Charles University, 120 00 Prague, Czech Republic $u Department of Oncology, General University Hospital, 128 08 Prague, Czech Republic $1 https://orcid.org/000000029386657X $7 xx0181880
700    1_
$a Argalácsová, Soňa $u 1st Medical Faculty, Charles University, 120 00 Prague, Czech Republic $u Department of Oncology, General University Hospital, 128 08 Prague, Czech Republic
700    1_
$a Dytrych, Petr $u 1st Department of Surgery, General University Hospital, 128 08 Prague, Czech Republic $u 1st Medical Faculty, Charles University, 120 00 Prague, Czech Republic
773    0_
$w MED00173178 $t Cancers $x 2072-6694 $g Roč. 16, č. 8 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38672641 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151447 $b ABA008
999    __
$a ok $b bmc $g 2125546 $s 1224832
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 16 $c 8 $e 20240419 $i 2072-6694 $m Cancers $n Cancers (Basel) $x MED00173178
GRA    __
$a without number $p Cooperatio Program, research area Surgical Disciplines, Abdominal Surgery
GRA    __
$a without number $p Ministry of Health, Czech Republic-conceptual development of research organization 00064165, General University Hospital in Prague
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Možnosti archivace